Evolocumab
Products in Health Canada’s databases that list Evolocumab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 2
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 13
- Products in all
- 2
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| REPATHA (140 MG) | 02446057 | Marketed | Amgen Canada Inc | |
| REPATHA (120 MG) | 02459779 | Cancelled Post Market | Amgen Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- REPATHAMay 16, 2025 · NOC 35387
- REPATHASeptember 27, 2023 · NOC 31733
- REPATHAApril 21, 2022 · NOC 28004
- REPATHADecember 9, 2021 · NOC 27222
- REPATHAApril 22, 2021 · NOC 25793
- REPATHAOctober 30, 2020 · NOC 24542
- REPATHANovember 29, 2018 · NOC 21577
- REPATHAAugust 10, 2018 · NOC 21196
- REPATHAJuly 5, 2018 · NOC 21055
- REPATHAJune 5, 2018 · NOC 20938
- REPATHADecember 15, 2016 · NOC 18766
- REPATHASeptember 20, 2016 · NOC 18489
- REPATHA (EVOLOCUMAB)September 10, 2015 · NOC 17318